Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Roivant Sciences Ltd. (ROIV)
USD34.51
-1.46 (-4.06%)
GB NASDAQ Healthcare Biotechnology
Address
11-12 St. James's Square SW1Y 4LB
London, GB
London, GB
CEO
Matthew Gline
Website
roivant.com
IPO
2020-12-08
CIK 1635088 ISIN BMG762791017
Also trades on
NASDAQ Global Market · ROIV (USD)
NASDAQ Global Market · ROIVW (USD)
Description
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Montes Archimedes Acquisition Corp. | MAACU | 2021-05-14 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD34.51
-1.46 (-4.06%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
1.14
Float Shares
516.19M
Free Float %
71.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.29% | -3.80% | +6.21% | +2.21% | +42.14% | +36.31% | +174.91% | +226.13% | +200.30% | +184.42% | +184.42% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (15 ratings, all time)
Buy
Price Targets & DCF
Current price
34.51
Low
30.00
-13.1%
Consensus
37.17
+7.7%
Median
38.00
+10.1%
High
42.00
+21.7%
DCF (Unlevered)
2.88
-91.6%
DCF (Levered)
1.85
-94.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
92% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 10 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 3 |
39.67
+15.0%
|
| Last Quarter | 5 |
38.60
+11.9%
|
| Last Year | 16 |
30.44
-11.8%
|
| All Time | 28 |
23.80
-31.0%
|
Quality scores
Altman Z-Score
29.55
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-71.6% Q1'26: -66.7% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-79.2% Q1'26: +227.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-24,702.5% Q1'26: -6,550.8% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-15,560.6% Q1'26: -14,087.1% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-116.4% Q1'26: -100.7% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%-4.4% ★ Q1'26: +14.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.08× Q1'26: -0.08× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 8 Rev. Ana. 4 EPS Ana. |
Mar 2027 8 Rev. Ana. 4 EPS Ana. |
Mar 2028 8 Rev. Ana. 4 EPS Ana. |
Mar 2029 9 Rev. Ana. 7 EPS Ana. |
Mar 2030 4 Rev. Ana. 2 EPS Ana. |
Mar 2031 3 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
55.29M
est: 52.87M (+4.6%)
|
31.53M
est: 52.28M (-39.7%)
|
32.71M
est: 158.30M (-79.3%)
|
29.05M
est: 141.38M (-79.5%)
|
9.09M
6.63M – 11.56M
-93.6% YoY
|
76.52M
18.07M – 219.91M
+741.9% YoY
|
578.07M
93.94M – 1.18B
+655.5% YoY
|
1.83B
1.80B – 1.85B
+215.7% YoY
|
3.17B
494.83M – 8.94B
+73.5% YoY
|
4.70B
733.78M – 13.25B
+48.3% YoY
|
| EBITDA |
-910.77M
est: -52.87M (-1,622.7%)
|
-790.16M
est: -52.28M (-1,411.5%)
|
-802.89M
est: -158.30M (-407.2%)
|
-1.10B
est: -141.38M (-677.8%)
|
-9.09M
-11.56M – -6.63M
+93.6% YoY
|
-76.52M
-219.91M – -18.07M
-741.9% YoY
|
-578.07M
-1.18B – -93.94M
-655.5% YoY
|
-1.83B
-1.85B – -1.80B
-215.7% YoY
|
-3.17B
-8.94B – -494.83M
-73.5% YoY
|
-4.70B
-13.25B – -733.78M
-48.3% YoY
|
| EBIT |
-916.71M
est: -52.87M (-1,633.9%)
|
-809.01M
est: -52.28M (-1,447.6%)
|
-824.93M
est: -158.30M (-421.1%)
|
-1.11B
est: -141.38M (-687.7%)
|
-9.09M
-11.56M – -6.63M
+93.6% YoY
|
-76.52M
-219.91M – -18.07M
-741.9% YoY
|
-578.07M
-1.18B – -93.94M
-655.5% YoY
|
-1.83B
-1.85B – -1.80B
-215.7% YoY
|
-3.17B
-8.94B – -494.83M
-73.5% YoY
|
-4.70B
-13.25B – -733.78M
-48.3% YoY
|
| Net Income |
-845.26M
est: -855.81M (+1.2%)
|
-1.01B
est: -1.08B (+6.9%)
|
4.35B
est: 4.74B (-8.2%)
|
-171.98M
est: -361.34M (+52.4%)
|
-299.77M
-2.62B – 75.38M
+17.0% YoY
|
-874.11M
-919.32M – -828.90M
-191.6% YoY
|
-946.96M
-1.30B – -87.35M
-8.3% YoY
|
-77.77M
-3.86B – 4.38B
+91.8% YoY
|
847.67M
-82.13M – 2.86B
+1,190.0% YoY
|
1.64B
-158.99M – 5.53B
+93.6% YoY
|
| SGA |
775.03M
est: 717.07M (+8.1%)
|
383.45M
est: 709.03M (-45.9%)
|
416.13M
est: 4.22B (-90.1%)
|
591.41M
est: 3.77B (-84.3%)
|
242.04M
176.54M – 307.86M
-93.6% YoY
|
2.04B
481.18M – 5.86B
+741.9% YoY
|
15.40B
2.50B – 31.33B
+655.5% YoY
|
48.61B
48.00B – 49.21B
+215.7% YoY
|
84.35B
13.18B – 238.00B
+73.5% YoY
|
125.08B
19.54B – 352.93B
+48.3% YoY
|
| EPS |
-1.26
est: -1.18 (-6.8%)
|
-1.42
est: -1.59 (+10.6%)
|
5.55
est: 6.09 (-8.9%)
|
-0.24
est: -0.52 (+53.9%)
|
-1.12
-3.78 – 0.11
-115.3% YoY
|
-1.26
-1.32 – -1.19
-12.3% YoY
|
-1.01
-1.87 – -0.13
+20.1% YoY
|
0.17
-5.57 – 6.31
+116.7% YoY
|
1.22
-0.12 – 4.11
+627.1% YoY
|
2.37
-0.23 – 7.97
+93.6% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-26 | Guggenheim | Buy | Buy | Maintain |
| 2026-05-21 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-04-16 | Piper Sandler | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-26 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-807.84M
OE per share TTM
-1.14
Owner's Yield
-3.89%
Maintenance CapEx ratio
4.37%
Maint CapEx / Avg PPE
237.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
458
Total invested
14.66B
Insider transactions (90d)
10
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
458
+39 vs prev Q
New positions
89
Closed positions
52
Increased
259
Reduced
127
Put/Call ratio
0.76
Calls held
1.33M
Puts held
1.01M
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 1.03M +1.0M (+100.0%) | 22.31B +22.3B (+100.0%) | 0.15% +0.148 pp | 7.21% +7.215 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 2 | FMR LLC | 65.78M +5.0M (+8.2%) | 1.43B +508.0M (+55.3%) | 9.44% +0.507 pp | 0.07% +0.025 pp | USD10.76 +101.7% | 17 qtrs — |
| 3 | MORGAN STANLEY | 58.36M +14.0M (+31.7%) | 1.27B +595.8M (+88.8%) | 8.37% +1.859 pp | 0.08% +0.035 pp | USD13.34 +62.7% | 17 qtrs — |
| 4 | VANGUARD GROUP INC | 42.06M +3.3M (+8.4%) | 912.68M +325.6M (+55.5%) | 6.04% +0.331 pp | 0.01% +0.004 pp | USD12.19 +78.0% | 17 qtrs — |
| 5 | BLACKROCK, INC. | 41.17M +1.4M (+3.6%) | 893.40M +292.4M (+48.6%) | 5.91% +0.069 pp | 0.02% +0.005 pp | USD11.90 +82.4% | 6 qtrs — |
| 6 | QVT FINANCIAL LP | 26.39M -3.0M (-10.2%) | 572.60M +128.1M (+28.8%) | 3.79% -0.532 pp | 49.10% +17.728 pp | USD10.08 +115.3% | 17 qtrs — |
| 7 | UBS GROUP AG | 18.39M +15.6M (+570.0%) | 399.08M +357.5M (+860.9%) | 2.64% +2.236 pp | 0.06% +0.058 pp | USD20.15 +7.7% | 13 qtrs — |
| 8 | STATE STREET CORP | 17.36M -1.3M (-7.2%) | 376.74M +93.8M (+33.2%) | 2.49% -0.258 pp | 0.01% +0.003 pp | USD9.66 +124.6% | 17 qtrs — |
| 9 | SB INVESTMENT ADVISERS (UK) LTD | 16.41M -23.9M (-59.3%) | 356.18M -253.8M (-41.6%) | 2.36% -3.571 pp | 3.56% -1.038 pp | USD10.08 +115.3% | 17 qtrs — |
| 10 | GOLDMAN SACHS GROUP INC | 10.98M +8.6M (+365.2%) | 238.32M +202.6M (+567.1%) | 1.58% +1.229 pp | 0.03% +0.025 pp | USD19.37 +12.0% | 16 qtrs — |
| 11 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 10.68M +3.4M (+47.6%) | 231.71M +122.3M (+111.8%) | 1.53% +0.469 pp | 0.35% +0.177 pp | USD15.89 +36.6% | 15 qtrs — |
| 12 | DIMENSIONAL FUND ADVISORS LP | 9.25M -61.2K (-0.7%) | 200.67M +59.8M (+42.5%) | 1.33% -0.041 pp | 0.04% +0.012 pp | USD11.54 +88.0% | 7 qtrs — |
| 13 | RUBRIC CAPITAL MANAGEMENT LP | 9.00M -11.0M (-55.0%) | 195.30M -107.3M (-35.5%) | 1.29% -1.648 pp | 2.34% -1.079 pp | USD10.81 +100.7% | 13 qtrs — |
| 14 | PATIENT SQUARE CAPITAL LP | 8.17M -4.3M (-34.6%) | 177.20M -11.6M (-6.2%) | 1.17% -0.663 pp | 37.93% -12.572 pp | USD9.01 +140.8% | 13 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 8.15M -49.0K (-0.6%) | 176.97M +52.8M (+42.6%) | 1.17% -0.036 pp | 0.01% +0.003 pp | USD10.93 +98.5% | 17 qtrs — |
| 16 | PERCEPTIVE ADVISORS LLC | 7.99M +617.0K (+8.4%) | 173.28M +61.8M (+55.4%) | 1.15% +0.063 pp | 3.09% -0.131 pp | USD14.03 +54.7% | 3 qtrs — |
| 17 | ASSENAGON ASSET MANAGEMENT S.A. | 6.94M +6.9M (+11,507.5%) | 150.54M +149.6M (+16,547.9%) | 1.02% +1.010 pp | 0.21% +0.206 pp | USD21.60 +0.5% | 4 qtrs — |
| 18 | VIKING GLOBAL INVESTORS LP | 6.44M -17.2M (-72.7%) | 139.82M -217.2M (-60.8%) | 0.92% -2.544 pp | 0.37% -0.556 pp | USD10.08 +115.3% | 17 qtrs — |
| 19 | BAKER BROS. ADVISORS LP | 5.56M +1.8M (+47.4%) | 120.54M +63.5M (+111.5%) | 0.80% +0.243 pp | 0.71% +0.294 pp | USD13.76 +57.7% | 13 qtrs — |
| 20 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.34M +2.4M (+82.7%) | 115.77M +71.6M (+162.0%) | 0.77% +0.336 pp | 0.01% +0.008 pp | USD17.05 +27.3% | 11 qtrs — |
| 21 | NORGES BANK | 5.20M +5.2M (+100.0%) | 112.75M +112.8M (+100.0%) | 0.75% +0.746 pp | 0.01% +0.012 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 22 | JEFFERIES FINANCIAL GROUP INC. | 3.51M +3.5M (+100.0%) | 76.27M +76.3M (+100.0%) | 0.50% +0.504 pp | 0.39% +0.390 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 23 | MARSHALL WACE, LLP | 3.46M -519.1K (-13.0%) | 75.06M +14.9M (+24.7%) | 0.50% -0.088 pp | 0.07% +0.007 pp | USD14.22 +52.6% | 14 qtrs — |
| 24 | ADAR1 CAPITAL MANAGEMENT, LLC | 3.43M +81.5K (+2.4%) | 74.41M +23.8M (+46.9%) | 0.49% +0.000 pp | 5.46% +0.707 pp | USD12.92 +68.0% | 9 qtrs — |
| 25 | NORTHERN TRUST CORP | 3.29M +2.9K (+0.1%) | 71.30M +21.6M (+43.5%) | 0.47% -0.011 pp | 0.01% +0.003 pp | USD10.79 +101.1% | 17 qtrs — |
| 26 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.24M +122.0K (+3.9%) | 70.30M +23.1M (+49.0%) | 0.46% +0.007 pp | 0.01% +0.003 pp | USD11.82 +83.6% | 17 qtrs — |
| 27 | BLACKBARN CAPITAL PARTNERS LP | 3.08M -1.3M (-29.9%) | 66.93M +357.3K (+0.5%) | 0.44% -0.204 pp | 4.40% -0.364 pp | USD10.99 +97.5% | 9 qtrs — |
| 28 | BANK OF AMERICA CORP /DE/ | 2.93M +240.5K (+8.9%) | 63.54M +22.9M (+56.3%) | 0.42% +0.025 pp | 0.00% +0.002 pp | USD11.02 +96.9% | 16 qtrs — |
| 29 | JANUS HENDERSON GROUP PLC | 2.92M +2.8M (+1,943.8%) | 63.28M +61.1M (+2,830.2%) | 0.42% +0.398 pp | 0.03% +0.027 pp | USD21.04 +3.1% | 15 qtrs — |
| 30 | BANK OF NEW YORK MELLON CORP | 2.90M -1.7M (-37.3%) | 63.00M -7.1M (-10.1%) | 0.42% -0.264 pp | 0.01% -0.002 pp | USD10.82 +100.6% | 17 qtrs — |
| 31 | POLAR CAPITAL HOLDINGS PLC | 2.69M +731.4K (+37.3%) | 58.38M +28.7M (+97.0%) | 0.39% +0.098 pp | 0.23% +0.083 pp | USD15.06 +44.1% | 8 qtrs — |
| 32 | CANDRIAM S.C.A. | 2.49M +332.4K (+15.4%) | 54.04M +21.4M (+65.5%) | 0.36% +0.040 pp | 0.27% +0.098 pp | USD13.66 +58.9% | 4 qtrs — |
| 33 | TWO SEAS CAPITAL LP | 2.44M +— (+0.0%) | 52.85M +16.0M (+43.4%) | 0.35% -0.009 pp | 1.09% +0.497 pp | USD15.13 +43.4% | 2 qtrs — |
| 34 | JENNISON ASSOCIATES LLC | 2.35M +2.4M (+100.0%) | 51.07M +51.1M (+100.0%) | 0.35% +0.346 pp | 0.03% +0.031 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 35 | PICTET ASSET MANAGEMENT HOLDING SA | 2.31M +2.1M (+790.3%) | 50.18M +46.3M (+1,178.9%) | 0.34% +0.301 pp | 0.05% +0.045 pp | USD20.53 +5.7% | 10 qtrs — |
| 36 | BNP PARIBAS ARBITRAGE, SNC | 2.29M +534.6K (+30.4%) | 49.79M +23.2M (+87.0%) | 0.33% +0.071 pp | 0.02% +0.008 pp | USD16.43 +32.1% | 5 qtrs — |
| 37 | INVESCO LTD. | 2.28M +512.1K (+28.9%) | 49.51M +22.7M (+84.9%) | 0.33% +0.067 pp | 0.01% +0.003 pp | USD13.60 +59.6% | 15 qtrs — |
| 38 | NUVEEN, LLC | 2.25M -43.1K (-1.9%) | 48.82M +14.1M (+40.7%) | 0.32% -0.014 pp | 0.01% +0.004 pp | USD10.12 +114.4% | 4 qtrs — |
| 39 | ORBIMED ADVISORS LLC | 2.19M -523.9K (-19.3%) | 47.54M +6.5M (+15.7%) | 0.31% -0.085 pp | 0.97% +0.006 pp | USD11.27 +92.5% | 3 qtrs — |
| 40 | WHITEFORT CAPITAL MANAGEMENT, LP | 2.12M -1.4M (-40.0%) | 46.00M -7.4M (-13.9%) | 0.30% -0.215 pp | 11.76% -4.034 pp | USD10.77 +101.5% | 9 qtrs — |
| 41 | UBS ASSET MANAGEMENT AMERICAS INC | 2.08M -39.0K (-1.8%) | 45.24M +13.1M (+40.8%) | 0.30% -0.013 pp | 0.01% +0.003 pp | USD10.68 +103.2% | 15 qtrs — |
| 42 | DME CAPITAL MANAGEMENT, LP | 2.07M -206.2K (-9.1%) | 44.90M +10.5M (+30.4%) | 0.30% -0.038 pp | 1.58% +0.221 pp | USD10.57 +105.3% | 8 qtrs — |
| 43 | NATIONAL BANK OF CANADA /FI/ | 2.04M +2.0M (+100.0%) | 44.27M +44.3M (+100.0%) | 0.29% +0.293 pp | 0.04% +0.040 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 44 | CLEARBRIDGE INVESTMENTS, LLC | 1.97M +141.5K (+7.7%) | 42.81M +15.1M (+54.5%) | 0.28% +0.014 pp | 0.03% +0.013 pp | USD11.36 +91.0% | 8 qtrs — |
| 45 | PENN DAVIS MCFARLAND INC | 1.86M -3.8K (-0.2%) | 40.32M +12.2M (+43.1%) | 0.27% -0.001 pp | 3.86% +0.952 pp | USD10.86 +99.8% | 8 qtrs — |
| 46 | WOODLINE PARTNERS LP | 1.75M -1.3M (-42.9%) | 37.98M -8.4M (-18.1%) | 0.25% -0.200 pp | 0.15% -0.071 pp | USD9.56 +127.0% | 14 qtrs — |
| 47 | CITIGROUP INC | 1.71M -47.9K (-2.7%) | 37.14M +10.5M (+39.5%) | 0.25% -0.013 pp | 0.02% +0.005 pp | USD11.82 +83.6% | 17 qtrs — |
| 48 | AFFINITY ASSET ADVISORS, LLC | 1.70M +900.0K (+112.5%) | 36.89M +24.8M (+204.8%) | 0.24% +0.126 pp | 2.10% +1.048 pp | USD17.60 +23.3% | 12 qtrs — |
| 49 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.67M -608.4K (-26.7%) | 36.30M +1.8M (+5.2%) | 0.24% -0.095 pp | 0.13% +0.012 pp | USD15.13 +43.4% | 2 qtrs — |
| 50 | MAN GROUP PLC | 1.46M +973.0K (+201.0%) | 31.62M +24.3M (+331.7%) | 0.21% +0.138 pp | 0.05% +0.041 pp | USD19.11 +13.6% | 3 qtrs — |
| 51 | BANK OF NOVA SCOTIA | 1.42M +1.4M (+100.0%) | 30.88M +30.9M (+100.0%) | 0.20% +0.204 pp | 0.05% +0.046 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 52 | MILLENNIUM MANAGEMENT LLC | 1.20M -1.4M (-53.7%) | 25.99M -13.2M (-33.6%) | 0.17% -0.209 pp | 0.01% -0.006 pp | USD13.62 +59.3% | 4 qtrs — |
| 53 | FIRST TURN MANAGEMENT, LLC | 1.19M +227.1K (+23.7%) | 25.75M +11.2M (+77.4%) | 0.17% +0.029 pp | 2.94% +0.762 pp | USD16.39 +32.4% | 2 qtrs — |
| 54 | PARKSIDE FINANCIAL BANK & TRUST | 1.17M +468.2K (+67.0%) | 25.32M +14.7M (+139.6%) | 0.17% +0.065 pp | 1.89% +1.076 pp | USD15.12 +43.5% | 12 qtrs — |
| 55 | AMUNDI | 1.04M +1.0M (+3,119.0%) | 22.64M +22.1M (+4,195.9%) | 0.15% +0.145 pp | 0.01% +0.006 pp | USD21.38 +1.5% | 13 qtrs — |
| 56 | RHUMBLINE ADVISERS | 1.04M +9.4K (+0.9%) | 22.52M +7.0M (+44.7%) | 0.15% -0.002 pp | 0.02% +0.006 pp | USD10.77 +101.5% | 11 qtrs — |
| 57 | STEMPOINT CAPITAL LP | 966.7K -3.2M (-77.0%) | 20.98M -42.5M (-67.0%) | 0.14% -0.478 pp | 3.60% -9.127 pp | USD14.53 +49.3% | 9 qtrs — |
| 58 | PRINCIPAL FINANCIAL GROUP INC | 941.2K -12.7K (-1.3%) | 20.42M +6.0M (+41.5%) | 0.14% -0.002 pp | 0.01% +0.003 pp | USD10.44 +107.9% | 11 qtrs — |
| 59 | JPMORGAN CHASE & CO | 934.5K -294.7K (-24.0%) | 20.28M +1.7M (+9.0%) | 0.14% -0.043 pp | 0.00% +0.000 pp | USD11.77 +84.4% | 15 qtrs — |
| 60 | GOTHAM ASSET MANAGEMENT, LLC | 925.2K +594.7K (+180.0%) | 20.08M +15.1M (+301.5%) | 0.13% +0.084 pp | 0.07% +0.052 pp | USD19.17 +13.2% | 7 qtrs — |
| 61 | AQR CAPITAL MANAGEMENT LLC | 880.8K +810.4K (+1,151.6%) | 18.99M +17.9M (+1,693.0%) | 0.13% +0.116 pp | 0.01% +0.009 pp | USD21.18 +2.5% | 2 qtrs — |
| 62 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 850.0K +100.0K (+13.3%) | 18.45M +7.1M (+62.5%) | 0.12% +0.012 pp | 0.92% +0.148 pp | USD12.35 +75.7% | 4 qtrs — |
| 63 | BARCLAYS PLC | 839.3K +379.8K (+82.6%) | 18.21M +12.9M (+243.4%) | 0.12% +0.053 pp | 0.00% +0.003 pp | USD15.50 +40.0% | 16 qtrs — |
| 64 | QUBE RESEARCH & TECHNOLOGIES LTD | 759.2K +759.2K (+100.0%) | 16.48M +16.5M (+100.0%) | 0.11% +0.109 pp | 0.02% +0.017 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 65 | SWISS NATIONAL BANK | 740.6K +147.4K (+24.8%) | 16.07M +7.1M (+79.1%) | 0.11% +0.019 pp | 0.01% +0.004 pp | USD9.86 +120.1% | 15 qtrs — |
| 66 | SOFINNOVA INVESTMENTS, INC. | 734.6K -2.4M (-76.7%) | 15.94M -31.7M (-66.5%) | 0.11% -0.358 pp | 0.69% -1.918 pp | USD10.86 +99.8% | 4 qtrs — |
| 67 | VERITION FUND MANAGEMENT LLC | 729.0K +99.5K (+15.8%) | 15.82M +6.3M (+66.1%) | 0.10% +0.012 pp | 0.06% +0.023 pp | USD13.64 +59.1% | 7 qtrs — |
| 68 | ALGERT GLOBAL LLC | 706.6K +706.6K (+100.0%) | 15.33M +15.3M (+100.0%) | 0.10% +0.101 pp | 0.24% +0.239 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 69 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 686.4K -179.3K (-20.7%) | 14.89M +1.8M (+13.7%) | 0.10% -0.029 pp | 0.00% +0.000 pp | USD13.09 +65.8% | 16 qtrs — |
| 70 | AMERIPRISE FINANCIAL INC | 645.4K +197.1K (+44.0%) | 14.01M +7.2M (+106.5%) | 0.09% +0.027 pp | 0.00% +0.002 pp | USD14.02 +54.8% | 8 qtrs — |
| 71 | ENVESTNET ASSET MANAGEMENT INC | 641.5K +603.2K (+1,575.3%) | 13.92M +13.3M (+2,302.8%) | 0.09% +0.086 pp | 0.00% +0.004 pp | USD21.09 +2.9% | 5 qtrs — |
| 72 | TORONTO DOMINION BANK | 631.0K +631.0K (+100.0%) | 13.69M +13.7M (+100.0%) | 0.09% +0.091 pp | 0.02% +0.020 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 73 | PROSIGHT MANAGEMENT, LP | 627.2K -708.3K (-53.0%) | 13.61M -6.6M (-32.6%) | 0.09% -0.106 pp | 2.81% -1.900 pp | USD10.39 +108.9% | 8 qtrs — |
| 74 | ROYAL BANK OF CANADA | 613.6K -1.9M (-75.7%) | 13.32M -24.9M (-65.1%) | 0.09% -0.283 pp | 0.00% -0.004 pp | USD12.56 +72.8% | 13 qtrs — |
| 75 | CENTERBOOK PARTNERS LP | 611.8K +364.4K (+147.3%) | 13.28M +9.5M (+254.6%) | 0.09% +0.051 pp | 0.65% +0.464 pp | USD18.22 +19.1% | 4 qtrs — |
| 76 | CAPTION MANAGEMENT, LLC | 609.2K -87.8K (-12.6%) | 13.22M +2.7M (+25.4%) | 0.09% -0.015 pp | 0.09% +0.008 pp | USD11.27 +92.5% | 3 qtrs — |
| 77 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 598.5K +131.3K (+28.1%) | 12.97M +5.9M (+83.4%) | 0.09% +0.017 pp | 0.01% +0.005 pp | USD14.11 +53.8% | 10 qtrs — |
| 78 | LEGAL & GENERAL GROUP PLC | 589.7K +40.3K (+7.3%) | 12.80M +4.5M (+54.0%) | 0.08% +0.004 pp | 0.00% +0.001 pp | USD10.24 +111.9% | 14 qtrs — |
| 79 | ING GROEP NV | 588.4K +588.4K (+100.0%) | 12.77M +12.8M (+100.0%) | 0.08% +0.084 pp | 0.08% +0.077 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 80 | TD ASSET MANAGEMENT INC | 551.4K +235.2K (+74.4%) | 11.96M +7.2M (+150.1%) | 0.08% +0.033 pp | 0.01% +0.006 pp | USD16.80 +29.2% | 3 qtrs — |
| 81 | IMPAX ASSET MANAGEMENT GROUP PLC | 550.0K -1.3M (-69.4%) | 11.94M -15.3M (-56.2%) | 0.08% -0.184 pp | 0.07% -0.084 pp | USD10.65 +103.8% | 8 qtrs — |
| 82 | ALLIANCEBERNSTEIN L.P. | 542.0K -14.8K (-2.7%) | 11.76M +3.3M (+39.6%) | 0.08% -0.004 pp | 0.00% +0.001 pp | USD10.65 +103.8% | 11 qtrs — |
| 83 | JANE STREET GROUP, LLC | 530.8K +146.5K (+38.1%) | 11.52M +5.7M (+98.1%) | 0.08% +0.020 pp | 0.00% +0.001 pp | USD15.60 +39.1% | 6 qtrs — |
| 84 | RETIREMENT SYSTEMS OF ALABAMA | 525.9K +5.7K (+1.1%) | 11.41M +3.5M (+45.0%) | 0.08% +0.001 pp | 0.04% +0.011 pp | USD10.83 +100.4% | 8 qtrs — |
| 85 | SQUAREPOINT OPS LLC | 517.0K -916.1K (-63.9%) | 11.22M -10.5M (-48.3%) | 0.07% -0.137 pp | 0.01% -0.010 pp | USD11.23 +93.2% | 4 qtrs — |
| 86 | MUFG SECURITIES EMEA PLC | 492.0K +492.0K (+100.0%) | 10.68M +10.7M (+100.0%) | 0.07% +0.071 pp | 0.12% +0.124 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 87 | GILDER GAGNON HOWE & CO LLC | 483.1K -12.8K (-2.6%) | 10.48M +3.0M (+39.7%) | 0.07% -0.004 pp | 0.11% +0.034 pp | USD11.83 +83.4% | 5 qtrs — |
| 88 | PDT PARTNERS, LLC | 464.9K -152.5K (-24.7%) | 10.09M +747.1K (+8.0%) | 0.07% -0.024 pp | 0.65% +0.065 pp | USD11.26 +92.7% | 9 qtrs — |
| 89 | CENTIVA CAPITAL, LP | 461.0K +— (+0.0%) | 10.00M +3.0M (+43.4%) | 0.07% -0.002 pp | 0.08% +0.015 pp | USD11.95 +81.6% | 3 qtrs — |
| 90 | CAPRICORN FUND MANAGERS LTD | 445.5K +247.0K (+124.4%) | 9.67M +6.7M (+221.9%) | 0.07% +0.036 pp | 2.33% +1.322 pp | USD18.77 +15.6% | 2 qtrs — |
| 91 | WEISS ASSET MANAGEMENT LP | 425.6K +376.2K (+761.3%) | 9.23M +8.5M (+1,135.3%) | 0.06% +0.054 pp | 0.13% +0.121 pp | USD20.94 +3.6% | 2 qtrs — |
| 92 | D. E. SHAW & CO., INC. | 395.4K -152.7K (-27.9%) | 8.58M +288.1K (+3.5%) | 0.06% -0.024 pp | 0.00% +0.000 pp | USD14.54 +49.2% | 3 qtrs — |
| 93 | PIER CAPITAL, LLC | 391.1K -3.6K (-0.9%) | 8.49M +2.5M (+42.1%) | 0.06% -0.001 pp | 1.35% +0.421 pp | USD8.23 +163.7% | 12 qtrs — |
| 94 | DORSEY WRIGHT & ASSOCIATES | 376.1K +376.1K (+100.0%) | 8.16M +8.2M (+100.0%) | 0.05% +0.054 pp | 1.78% +1.776 pp | USD21.70 +0.0% | 1 qtrs NEW |
| 95 | CITADEL ADVISORS LLC | 362.8K +110.1K (+43.6%) | 7.87M +4.0M (+105.9%) | 0.05% +0.015 pp | 0.00% +0.001 pp | USD15.26 +42.2% | 15 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.90
Neutral
Ratio by volume
0.52
Neutral
Buys
9
Sells
10
Shares acquired
603.0K
Shares disposed
1.16M
Cash buys
—
Cash sales
4.00
Net activity
-553,911
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | Venker Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 200,000 | 3.85 | 770.0K | 4,444,834 | D | ↗ |
| 2026-05-20 | Venker Eric | Officer | F-InKind | D | Common Shares | 34,483 | 32.41 | 1.12M | 1,613,063 | D | ↗ |
| 2026-05-20 | Pulik Richard | Officer | F-InKind | D | Common Shares | 18,962 | 32.41 | 614.6K | 278,549 | D | ↗ |
| 2026-04-20 | Venker Eric | Officer | S-Sale | D | Common Shares | 200,000 | 29.59 | 5.92M | 1,647,546 | D | ↗ |
| 2026-04-20 | Pulik Richard | Officer | A-Award | A | Common Shares | 60,644 | 0.00 | — | 297,511 | D | ↗ |
| 2026-04-20 | Humes Jennifer | Officer | A-Award | A | Stock Option (Right to Buy) | 27,157 | 29.08 | 789.7K | 27,157 | D | ↗ |
| 2026-04-17 | Oren Ilan | Director | A-Award | A | Common Shares | 896 | 0.00 | — | 120,324 | D | ↗ |
| 2026-04-17 | MOMTAZEE JAMES C | Director | A-Award | A | Common Shares | 469 | 0.00 | — | 109,499 | D | ↗ |
| 2026-04-17 | Epperly Melissa B, | Director | A-Award | A | Common Shares | 670 | 0.00 | — | 16,474 | D | ↗ |
| 2026-04-16 | Gline Matthew | Director / Officer | S-Sale | D | Common Shares | 289,774 | 29.16 | 8.45M | 16,736,116 | D | ↗ |
| 2026-04-08 | Humes Jennifer | Officer | S-Sale | D | Common Shares | 13,538 | 28.37 | 384.1K | 84,191 | D | ↗ |
| 2026-03-31 | Torti Frank | Officer | F-InKind | D | Common Shares | 160,035 | 27.70 | 4.43M | 13,576,512 | D | ↗ |
| 2026-03-31 | Sukhatme Mayukh | Director / Officer | F-InKind | D | Common Shares | 187,512 | 27.70 | 5.19M | 18,677,617 | D | ↗ |
| 2026-03-31 | Gline Matthew | Director / Officer | F-InKind | D | Common Shares | 304,684 | 27.70 | 8.44M | 17,025,890 | D | ↗ |
| 2026-03-30 | Sukhatme Mayukh | Director / Officer | M-Exempt | A | Common Shares | 58,391 | 12.68 | 740.4K | 18,894,938 | D | ↗ |
| 2026-03-30 | Gline Matthew | Director / Officer | M-Exempt | A | Common Shares | 97,319 | 12.68 | 1.23M | 17,384,400 | D | ↗ |
| 2026-03-26 | Fitzgerald Meghan | Director | M-Exempt | A | Common Shares | 70,000 | 8.80 | 616.0K | 112,963 | D | ↗ |
| 2026-03-20 | Pulik Richard | Officer | F-InKind | D | Common Shares | 1,546 | 27.70 | 42.8K | 236,867 | D | ↗ |
| 2026-03-20 | Humes Jennifer | Officer | F-InKind | D | Common Shares | 14,526 | 27.70 | 402.4K | 97,729 | D | ↗ |
| 2026-03-17 | Venker Eric | Officer | S-Sale | D | Common Shares | 200,000 | 28.24 | 5.65M | 1,647,546 | D | ↗ |
| 2026-03-16 | Epperly Melissa B, | Director | S-Sale | D | Common Shares | 41,861 | 28.68 | 1.20M | 15,804 | D | ↗ |
| 2026-02-23 | Torti Frank | Officer | M-Exempt | A | Common Shares | 587,390 | 3.85 | 2.26M | 14,323,937 | D | ↗ |
| 2026-02-20 | Venker Eric | Officer | F-InKind | D | Common Shares | 7,051 | 27.15 | 191.4K | 1,647,546 | D | ↗ |
| 2026-02-20 | Torti Frank | Officer | M-Exempt | A | Common Shares | 1,012,610 | 3.85 | 3.90M | 14,749,157 | D | ↗ |
| 2026-02-20 | Pulik Richard | Officer | F-InKind | D | Common Shares | 1,000 | 27.15 | 27.2K | 238,413 | D | ↗ |
| 2026-02-19 | Torti Frank | Officer | S-Sale | D | Common Shares | 1,400,000 | 27.42 | 38.39M | 13,736,547 | D | ↗ |
| 2026-02-13 | Venker Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 200,000 | 3.85 | 770.0K | 5,044,834 | D | ↗ |
| 2026-02-13 | QVT Financial LP | Director | S-Sale | D | Common Shares | 150,784 | 26.49 | 3.99M | 15,352,329 | I | ↗ |
| 2026-02-13 | MANCHESTER KEITH S | Director | S-Sale | D | Common Shares | 150,784 | 26.49 | 3.99M | 15,352,329 | I | ↗ |
| 2026-02-13 | Gold Daniel Allen | Director | S-Sale | D | Common Shares | 225,000 | 26.50 | 5.96M | 15,127,329 | I | ↗ |
| 2026-02-12 | QVT Financial LP | Director | S-Sale | D | Common Shares | 275,000 | 26.76 | 7.36M | 15,503,113 | I | ↗ |
| 2026-02-12 | MANCHESTER KEITH S | Director | S-Sale | D | Common Shares | 275,000 | 26.76 | 7.36M | 15,503,113 | I | ↗ |
| 2026-02-12 | Gold Daniel Allen | Director | S-Sale | D | Common Shares | 275,000 | 26.76 | 7.36M | 15,503,113 | I | ↗ |
| 2026-02-11 | QVT Financial LP | Director | S-Sale | D | Common Shares | 425,000 | 26.67 | 11.33M | 15,928,113 | I | ↗ |
| 2026-02-11 | MANCHESTER KEITH S | Director | S-Sale | D | Common Shares | 425,000 | 26.67 | 11.33M | 15,928,113 | I | ↗ |
| 2026-02-11 | Gold Daniel Allen | Director | S-Sale | D | Common Shares | 425,000 | 26.67 | 11.33M | 15,928,113 | I | ↗ |
| 2026-02-09 | Sukhatme Mayukh | Director / Officer | S-Sale | D | Common Shares | 339,441 | 26.47 | 8.99M | 19,148,664 | D | ↗ |
| 2026-01-20 | Oren Ilan | Director | A-Award | A | Common Shares | 1,164 | 0.00 | — | 119,552 | D | ↗ |
| 2026-01-20 | MOMTAZEE JAMES C | Director | A-Award | A | Common Shares | 609 | 0.00 | — | 109,152 | D | ↗ |
| 2026-01-20 | Epperly Melissa B, | Director | A-Award | A | Common Shares | 815 | 0.00 | — | 57,719 | D | ↗ |
| 2026-01-12 | Venker Eric | Officer | M-Exempt | A | Common Shares | 200,000 | 3.85 | 770.0K | 1,854,597 | D | ↗ |
| 2025-12-31 | Sukhatme Mayukh | Director / Officer | S-Sale | D | Common Shares | 1,018,995 | 21.71 | 22.12M | 20,267,429 | D | ↗ |
| 2025-12-29 | Sukhatme Mayukh | Director / Officer | M-Exempt | A | Common Shares | 748,358 | 12.68 | 9.49M | 19,584,905 | D | ↗ |
| 2025-12-24 | Venker Eric | Officer | S-Sale | D | Common Shares | 75,000 | 22.53 | 1.69M | 1,654,597 | D | ↗ |
| 2025-12-24 | Torti Frank | Officer | G-Gift | D | Common Shares | 110,489 | 0.00 | — | 13,736,547 | D | ↗ |
| 2025-12-23 | Venker Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 313,841 | 3.85 | 1.21M | 5,562,682 | D | ↗ |
| 2025-12-23 | Torti Frank | Officer | A-Award | A | Common Shares | 175,380 | 22.45 | 3.94M | 13,911,927 | D | ↗ |
| 2025-12-23 | Pulik Richard | Officer | M-Exempt | D | Stock Option (Right to Buy) | 260,000 | 3.85 | 1.00M | 740,000 | D | ↗ |
| 2025-12-20 | Pulik Richard | Officer | F-InKind | D | Common Shares | 2,129 | 22.41 | 47.7K | 386,144 | D | ↗ |
| 2025-12-17 | Sukhatme Mayukh | Director / Officer | M-Exempt | D | Common Shares | 59,513 | 12.68 | 754.6K | 1,304,198 | D | ↗ |
| 2025-12-17 | QVT Financial LP | Director | S-Sale | D | Common Shares | 189,538 | 23.17 | 4.39M | 16,353,113 | I | ↗ |
| 2025-12-17 | MANCHESTER KEITH S | Director | S-Sale | D | Common Shares | 189,538 | 23.17 | 4.39M | 16,353,113 | I | ↗ |
| 2025-12-17 | Gold Daniel Allen | Director | S-Sale | D | Common Shares | 155,076 | 23.02 | 3.57M | 16,542,651 | I | ↗ |
| 2025-12-16 | QVT Financial LP | Director | S-Sale | D | Common Shares | 275,000 | 22.93 | 6.31M | 17,772,727 | I | ↗ |
| 2025-12-16 | MANCHESTER KEITH S | Director | S-Sale | D | Common Shares | 642,282 | 23.08 | 14.82M | 17,130,445 | I | ↗ |
| 2025-12-16 | Gold Daniel Allen | Director | S-Sale | D | Common Shares | 275,000 | 22.93 | 6.31M | 17,772,727 | I | ↗ |
| 2025-12-15 | Ramaswamy Vivek | 10% Owner | J-Other | D | Common Shares | 478,708 | 22.05 | 10.56M | 33,653,755 | D | ↗ |
| 2025-12-15 | Gline Matthew | Director / Officer | J-Other | D | Common Shares | 1,329,325 | 21.68 | 28.82M | 17,287,081 | D | ↗ |
| 2025-12-12 | Ramaswamy Vivek | 10% Owner | M-Exempt | A | Common Shares | 4,672,724 | 12.68 | 59.25M | 38,326,479 | D | ↗ |
| 2025-12-11 | Ramaswamy Vivek | 10% Owner | M-Exempt | A | Common Shares | 1,869,691 | 12.68 | 23.71M | 35,523,447 | D | ↗ |
| 2025-12-09 | Venker Eric | Officer | S-Sale | D | Common Shares | 200,000 | 20.85 | 4.17M | 1,497,908 | D | ↗ |
| 2025-11-20 | Venker Eric | Officer | F-InKind | D | Common Shares | 7,051 | 20.27 | 142.9K | 1,497,908 | D | ↗ |
| 2025-11-20 | Pulik Richard | Officer | F-InKind | D | Common Shares | 1,235 | 20.27 | 25.0K | 388,273 | D | ↗ |
| 2025-11-19 | QVT Financial LP | Director | S-Sale | D | Common Shares | 175,000 | 20.24 | 3.54M | 18,047,727 | I | ↗ |
| 2025-11-19 | MANCHESTER KEITH S | Director | S-Sale | D | Common Shares | 175,000 | 20.24 | 3.54M | 18,047,727 | I | ↗ |
| 2025-11-19 | Gold Daniel Allen | Director | S-Sale | D | Common Shares | 125,000 | 20.16 | 2.52M | 18,222,727 | I | ↗ |
| 2025-11-17 | Ramaswamy Vivek | 10% Owner | S-Sale | D | Common Shares | 539,650 | 20.51 | 11.07M | 33,653,756 | D | ↗ |
| 2025-11-14 | Ramaswamy Vivek | 10% Owner | S-Sale | D | Common Shares | 1,027,670 | 20.33 | 20.89M | 34,193,406 | D | ↗ |
| 2025-11-13 | Ramaswamy Vivek | 10% Owner | S-Sale | D | Common Shares | 287,283 | 20.81 | 5.98M | 35,221,076 | D | ↗ |
| 2025-11-07 | Venker Eric | Officer | M-Exempt | A | Common Shares | 200,000 | 3.85 | 770.0K | 1,704,959 | D | ↗ |
| 2025-10-20 | Oren Ilan | Director | A-Award | A | Common Shares | 1,507 | 0.00 | — | 118,669 | D | ↗ |
| 2025-10-20 | MOMTAZEE JAMES C | Director | A-Award | A | Common Shares | 789 | 0.00 | — | 108,701 | D | ↗ |
| 2025-10-20 | Epperly Melissa B, | Director | A-Award | A | Common Shares | 1,056 | 0.00 | — | 56,904 | D | ↗ |
| 2025-10-17 | Venker Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 118,418 | 15.85 | 1.88M | 0 | D | ↗ |
| 2025-10-16 | Venker Eric | Officer | M-Exempt | A | Common Shares | 318,282 | 15.85 | 5.04M | 1,823,241 | D | ↗ |
| 2025-10-15 | Venker Eric | Officer | M-Exempt | D | Stock Option (Right to Buy) | 414,683 | 15.85 | 6.57M | 436,700 | D | ↗ |
| 2025-10-13 | Venker Eric | Officer | M-Exempt | A | Common Shares | 20,727 | 15.85 | 328.5K | 1,525,686 | D | ↗ |
| 2025-10-09 | Venker Eric | Officer | M-Exempt | A | Common Shares | 104,940 | 15.85 | 1.66M | 1,609,899 | D | ↗ |
| 2025-10-08 | Venker Eric | Officer | M-Exempt | A | Common Shares | 128,295 | 7.45 | 955.8K | 1,643,561 | D | ↗ |
| 2025-10-07 | Venker Eric | Officer | M-Exempt | A | Common Shares | 107,131 | 7.45 | 798.1K | 1,679,261 | D | ↗ |
| 2025-10-06 | Venker Eric | Officer | M-Exempt | A | Common Shares | 19,141 | 3.85 | 73.7K | 1,676,355 | D | ↗ |
Executive team
Top executives
Executive team data is not available for this company yet.
EBIT / Employee
-14.2K
Shares Outstanding
719.27M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-06-17 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ROIV
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
